<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="92440">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01935154</url>
  </required_header>
  <id_info>
    <org_study_id>Vx-001-201</org_study_id>
    <nct_id>NCT01935154</nct_id>
  </id_info>
  <brief_title>Efficacy Study of Vx001 Vaccine in NSCLC Patients</brief_title>
  <official_title>Phase II Study of Vx001 Vaccine in HLA-A*0201 Positive Patients With TERT Positive Stage IV or Recurrent Stage I-III NSCLC</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vaxon Biotech</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vaxon Biotech</source>
  <oversight_info>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
    <authority>Spain: Agencia Española de Medicamentos y Productos Sanitarios</authority>
    <authority>Greece: National Organization of Medicines</authority>
    <authority>Italy: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with stage IV or recurrent stage I-III NSCLC with documented disease control
      (objective response or stable disease) within 3 weeks after platinum based 1st line
      chemotherapy; only HLA-A*0201 positive patients with TERT expressing tumors will be
      included.

      The objective of the trial is survival rate at 12 months.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2012</start_date>
  <completion_date type="Anticipated">April 2015</completion_date>
  <primary_completion_date type="Anticipated">April 2015</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Overal survival rate</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time-to-event comparison of overall survival (OS) in Vx-001 treated vs placebo treated patients.</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of Time to Treatment Failure in Vx-001 treated vs placebo treated patients.</measure>
    <time_frame>Traitement failure</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Comparison of vaccine induced immune responses between Vx-001 vs placebo in terms of frequency of TERT specific IFN-γ and granzyme-B producing T cells in the blood of patients.</measure>
    <time_frame>week 18</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">220</enrollment>
  <condition>Non-small Cell Lung Cancer Metastatic</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo will be administered evey 3 weeks from w0 to W15 than every 12 weeks until disease progression.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vx-001</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Vx-001 will be administered evey 3 weeks from w0 to W15 than every 12 weeks until disease progression.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vx-001</intervention_name>
    <arm_group_label>Vx-001</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Main Inclusion Criteria:

          1. Male or female ≥18 years of age;

          2. Documented stage IV NSCLC as defined by IASLC Lung Cancer Staging Project (7th
             edition) or recurrent stage I-III disease at least 6 months after resection or after
             the end of adjuvant chemotherapy or after standard locoregional treatment as defined
             by the American College of Chest Physicians;

          3. Patients treated with 4 cycles platinum based 1st line chemotherapy as defined by the
             American College of Chest Physicians (i.e. radiotherapy are not allowed except
             palliative radiotherapy of bone metastasis);

          4. Documented HLA-A*0201 positivity, as determined by a local laboratory;

          5. TERT-positive NSCLC, as assessed by a central laboratory; for this, availability of
             adequate tissue biopsy from the primary tumor, lymph nodes or distant metastases is a
             prerequisite;

          6. CR, PR, or SD according to RECIST 1.1 criteria after the completion of platinum-based
             first-line chemotherapy;

          7. ECOG performance status 0, 1;

        Main Exclusion Criteria:

          1. Mixed small cell and NSCLC histologies;

          2. Patients with stage IV or recurrent NSCLC who have been previously treated with
             therapy other than platinum-based first-line chemotherapy;

          3. Prior treatment with cancer vaccines;

          4. Prior treatment with immunotherapy (e.g., interferons, interleukins, TNF, or
             biological response modifiers, such as GM-CSF etc) within four weeks prior to
             randomization;

          5. Prior treatment with hormone (including corticosteroids) within 2 weeks prior to
             randomization;

          6. Prior treatment with any investigational drugs, within 4 weeks prior to
             randomization;

          7. Patients with brain metastases;
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vassilis Georgoulias, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University hospital of Heraklion</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Konstantinos Kosmatopoulos, MD, PhD</last_name>
    <phone>33 1 45 88 67 62</phone>
    <email>kkosmatopoulos@vaxon-biotech.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marina ICHE</last_name>
    <phone>33 1 45 88 67 62</phone>
    <email>marina.iche@vaxon-biotech.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital of Angers</name>
      <address>
        <city>Angers</city>
        <zip>49033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thierry Urban</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ambroise Paré Hospital</name>
      <address>
        <city>Boulogne Billancourt</city>
        <zip>92100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thierry Chinet</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>St Joseph-St Luc Hospital</name>
      <address>
        <city>Lyon</city>
        <zip>69007</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sylvie Vuillermoz-Blas</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Nord</name>
      <address>
        <city>Marseille</city>
        <zip>13915</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fabrice Barlesi</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pitié-Salpetrière Hospital</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Khayat</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pontchaillou Hospital</name>
      <address>
        <city>Rennes</city>
        <zip>35033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hervé Léna</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Center Réné Gauducheau</name>
      <address>
        <city>Saint Herblain</city>
        <zip>44805</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Yves Douillard</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Grosshansdorf</name>
      <address>
        <city>Grosshansdorf</city>
        <zip>22927</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Niels Reinmuth</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Medical center Kiel</name>
      <address>
        <city>Kiel</city>
        <zip>24116</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benedikt Gahn</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinik Löwenstein</name>
      <address>
        <city>Löwenstein</city>
        <zip>74245</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jürgen Fischer</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chirurgische Klinik-Inderdisziplinäre Thorakale Oncologie</name>
      <address>
        <city>Mannheim</city>
        <zip>68167</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Manegold</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>LMU Klinikum der Universität München</name>
      <address>
        <city>Munich</city>
        <zip>80336</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rudolf Huber</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pius Hospital Oldenburg</name>
      <address>
        <city>Oldenburg</city>
        <zip>26121</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frank Griesinger</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mathias Spital Rheine Medizinische Klinik V</name>
      <address>
        <city>Rheine</city>
        <zip>48431</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicolas Dickgreber</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital of Alexandroupolis</name>
      <address>
        <city>Alexandroupolis</city>
        <zip>68100</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stylianos Kakolyris</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital of Alexandroupolis</name>
      <address>
        <city>Alexandroupolis</city>
        <zip>68100</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marios Froudarakis</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Iaso General Hospital Cholargos</name>
      <address>
        <city>Athens</city>
        <zip>15562</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stylianos Giassas</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>General Hospital Alexandra</name>
      <address>
        <city>Athens</city>
        <zip>11528</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eleni Efstathiou</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>251 General Airforce Hospital</name>
      <address>
        <city>Athens</city>
        <zip>11525</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nikolaos Kentepozidis</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital of Heraklion</name>
      <address>
        <city>Heraklion</city>
        <zip>71110</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vassilis Georgoulias</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University General Hospital of Ioannina</name>
      <address>
        <city>Ioannina</city>
        <zip>45500</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nikolaos Pavlidis</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>General Oncology Hospital of Kifissia Agioi Anargyroi</name>
      <address>
        <city>Nea Kifissia</city>
        <zip>14564</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Epaminondas Samantas</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital of Rio</name>
      <address>
        <city>Patras</city>
        <zip>26504</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charalambos Kalofonos</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University General Hospital Papageorgiou</name>
      <address>
        <city>Thessaloniki</city>
        <zip>56429</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>George Foutzilas</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>General Hospital G. Papanikolaou</name>
      <address>
        <city>Thessaloniki</city>
        <zip>57010</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Konstantinos Zarogoulidis</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>SG Moscati Hospital</name>
      <address>
        <city>Avellino</city>
        <zip>83100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cesare Gridelli</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>G. Rummo Hospital</name>
      <address>
        <city>Benevento</city>
        <zip>82100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bruno Daniele</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mater Domini Catanzaro Hospital</name>
      <address>
        <city>Catanzaro</city>
        <zip>88100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Piersandro Tagliaferri</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>San Paolo Hospital</name>
      <address>
        <city>Milan</city>
        <zip>20142</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paolo Foa</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>European Institute of Oncology</name>
      <address>
        <city>Milan</city>
        <zip>20141</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tommaso De Pas</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Seconda Universita degli Studi Napoli Hospital</name>
      <address>
        <city>Naples</city>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fortunato Ciardiello</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Insituto Oncologico Veneto</name>
      <address>
        <city>Padova</city>
        <zip>35128</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adolfo Favaretto</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pisa Hospital</name>
      <address>
        <city>Pisa</city>
        <zip>56126</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonio Chella</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>S. Maria Nuova Hospital</name>
      <address>
        <city>Reggio Emilia</city>
        <zip>42100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Corrado Boni</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital of Siena</name>
      <address>
        <city>Siena</city>
        <zip>53100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michele Maio</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital of Siena</name>
      <address>
        <city>Siena</city>
        <zip>53100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierpaolo Correale</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital P. Vall d'Hebron</name>
      <address>
        <city>Barcelona</city>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Enriqueta Felip</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>USP Institut Universitari Dexeus</name>
      <address>
        <city>Barcelona</city>
        <zip>08028</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Santiago Viteri</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital de la Santa Creu I Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <zip>08041</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Margarita Magem Tarruella</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ico-Hospital Germans Trias I Pujol</name>
      <address>
        <city>Barcelona</city>
        <zip>08916</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Enric Carcereny</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Provencial de Castellón</name>
      <address>
        <city>Castellón</city>
        <zip>12002</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ramon de las Peñas</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oncologia Medica FUNDACIÓN JIMÉNEZ DÍAZ</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manuel Domine Gomez</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Univesitario Puerta de Hierro</name>
      <address>
        <city>Madrid</city>
        <zip>28222</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mariano Provencio Pulla</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>H.R.U. Carlos Haya Málaga</name>
      <address>
        <city>Málaga</city>
        <zip>29010</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manuel Cobo Dols</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Son Llatzer</name>
      <address>
        <city>Palma de Mallorca</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isabel Bover Barcelo</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico de Valencia</name>
      <address>
        <city>Valencia</city>
        <zip>46010</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amelia Insa</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
    <country>Germany</country>
    <country>Greece</country>
    <country>Italy</country>
    <country>Spain</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <lastchanged_date>September 17, 2013</lastchanged_date>
  <firstreceived_date>August 26, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>NSCLC</keyword>
  <keyword>Vaccine</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
